Warren Nachlis focuses on licensing and technology transactional matters for clients worldwide.
His practice includes a wide range of intellectual property-related matters, including licensing, joint ventures, joint development agreements, sponsored research agreements with academic and nonprofit organizations, development and supply agreements, technology issues, and strategic intellectual property counseling. Warren also routinely advises clients on intellectual property issues that arise in connection with larger corporate transactions such as mergers and acquisitions, capital markets offerings, secured lending transactions, asset securitizations, and private equity investments.
Warren has experience in a broad spectrum of technology areas with particular emphasis in the pharmaceutical, biotechnology, medical device, electronics, media, entertainment, and financial information industries. His representative clients include Astellas, Astra Zeneca, Celgene, City of Hope, Essilor, Kyowa Kirin, REGENXBIO, sanofi-aventis, SAP, Verint Systems, and Visible Alpha. In addition, Warren's experience includes patent litigation and interference matters, and he has a strong technical background in polymers, pharmaceuticals, chemistry, and biology.
Warren is a member of the Licensing Committee of the Intellectual Property Owners Association.
Antitrust Alert: FTC Expands Premerger Notification Requirements to Cover Certain Pharmaceutical Patent Licenses
Quanta Computer: The U.S. Supreme Court Breathes New Life into the Patent Exhaustion Defense, IP Perspectives
Supreme Court Breathes New Life Into Patent Exhaustion Defense, Metropolitan Corporate Counsel, Vol. 16, No. 7
Quanta Computer v. LG Electronics: The U.S. Supreme Court Breathes New Life Into the Patent Exhaustion Defense
- March 2015
BIO Conference on International Taxation in the Biopharmaceutical Industry
- November 13, 2013
2013-2014 Life Sciences Webinar Series: Intellectual Property, Regulatory, and Antitrust Issues in Life Sciences M&A and Capital Markets Transactions
- New York University (J.D. 1997); University of Massachusetts, Amherst (Ph.D. in Polymer Science and Engineering 1993); Franklin & Marshall College (B.A. in Chemistry 1987; Phi Beta Kappa)
- Massachusetts, New York, and registered to practice before the U.S. Patent and Trademark Office
Named in The Legal 500 US since 2008, which notes that he is well known for his technology transactions work
IAM Patent 1000 – The World's Leading Patent Practitioners since 2012
"Life Sciences Star," Euromoney's LMG Life Sciences since 2012
Managing Intellectual Property — IP Star since 2014
Massachusetts Super Lawyers (2017-2018)